In this review:
Melanoma diagnosis without the use of photographic surveillance
Practical office tips in the COVID era
Biologic therapy and cardiovascular risk parameters
Intralesional 5-fluorouracil for cutaneous squamous cell carcinomas
Algorithmic identification of naevi changes
Tildrakizumab for psoriatic arthritis affected by metabolic syndrome status
Biologic therapies and risk of major cardiovascular events
Hydrochlorothiazide and skin cancer risk
Bimekizumab for 2 years in moderate-to-severe plaque psoriasis
Strongyloides infection in immunosuppressed patients
Please login below to download this issue (PDF)